An exhalation delivery system that uses fluticasone reduced symptoms and improved quality of life for patients with chronic rhinosinusitis, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
In fact, this treatment is the first to achieve these outcomes without surgery regardless of nasal polyp status, James N. Palmer, MD, David W. Kennedy MD Endowed Professor of Otorhinolaryngology, Perelman School of Medicine, and colleagues wrote.
Although the treatment already is indicated for chronic rhinosinusitis with nasal polyps, Palmer told Healio, most